Title for MeetingAbstracts
Alphabetical listing of titles
-
Ritonavir-saquinavir (RTV/SQV) combination in protease inhibitor (PI) naive and pretreated HIV-infected patients.
-
Ritonavir/saquinavir (RTV/SQV) as salvage therapy after failure of initial protease inhibitor (PI) regimen.
-
Ritonavir/saquinavir versus ritonavir/saquinavir/stavudine in HIV-1-infected individuals during 48 weeks: the effect of treatment intensification.
-
Rituximab and infusional cyclophosphamide, doxorubicin and etoposide (CDE) in combination with HAART: A safe and highly active regimen in HIV-related non-Hodgkin's lymphomas.
-
Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide: A Safe and Highly Active Regimen in HIV-related Non-Hodgkin's Lymphomas.
-
Rituximab in HIV-related high-grade non-Hodgkin's lymphomas: preliminary results of an international multicenter pilot trial of rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide (cde).
-
RITUXIMAB-MEDIATED SIGNALING AND SENSITIZATION OF AIDS-RELATED NON-HODGKIN'S LYMPHOMA TO DRUG-MEDIATED APOPTOSIS.
-
rMamu-IL-12 Conditioning during Acute SIVmac251 Infection Leads to Decreased Viral Loads and Prolonged Survival.
-
RN characteristics and staffing patterns: a comparison of VHA and non-VHA hospital RNs in the United States.
-
RN Satisfaction: Evidence from the National Database of Nursing Quality Indicators.
-
RNA and DNA PCR for early diagnosis of infants born to HIV-infected mothers, Thailand.
-
RNA dependent cleavage of gag p15 by the HIV-1 protease.
-
RNA Incorporation is Critical for Retroviral Particle Stability after Release but Not for Particle Assembly.
-
RNA Interference of Chemokine Receptor Expression Allows for Inhibition of HIV-1 Replication.
-
RNA IS A STRUCTURAL ELEMENT IN RETROVIRUS PARTICLES.
-
RNA Isolation from Purified Cytomegalovirus Virions.
-
RNA Packaging and Gag Processing in SIV Require Multiple Interactions between Gag and Leader Sequences.
-
RNA profiles of Mycobacterium tuberculosis: implications for new drug development.
-
RNA splicing events detected in early in vitro HIV infection using the polymerase chain reaction (PCR).
-
RNA turnover in HIV/AIDS patients with tuberculosis.
-
RNA-mediated transfer of cellular immunity to a conserved epitope of glycoprotein 41 of HIV-1 to human lymphocytes.
-
RNA-protein complexes interfere with inhibition of reverse transcriptase.
-
RNA:RNA Junctions in Dimeric RNAs Isolated from Immature and Mature Murine Leukemia Virus Particles.
-
RNAi/SiRNAs for AIDS gene therapy.
-
RNAi: Ancient Pathways Programmed by Small RNAs.
-
RNase H domain of HIV-2: crystal structure and reconstitution of the activity.
-
RO 24-7429 (TAT antagonist) safety, tolerance, and pharmacokinetics in HIV-infected subjects.
-
Ro 31-8959, a specific inhibitor of HIV protease.
-
Ro 31-8959, an inhibitor of HIV proteinase, acts beneficially with other antiviral agents in 2- and 3-way combinations in vitro.
-
Ro 31-8959, an inhibitor of HIV proteinase, appears relatively refractory to the generation of virus mutants with reduced sensitivity.